Coronavirus (COVID-19) Collection
Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, IndonesiaHealthcare workers (HCWs) are at risk for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection due to increased occupational exposure to SARS-CoV-2 (Nguyen et al., 2020). As well as being beneficial for the HCWs themselves, protecting HCWs from SARS-CoV-2 infection is important to prevent disease transmission in healthcare and community settings (Anonymous, 2020). In addition, protecting HCWs from coronavirus disease 2019 (COVID-19) is crucial for the preservation and protection of national healthcare systems (Anonymous, 2020).
Post-vaccination cases of COVID-19 among healthcare workers at Siloam Teaching Hospital, IndonesiaCoronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has rapidly spread worldwide. Indonesia reported its first case of COVID-19 on 2 March 2020, and reached more than 1 million cases by February 2021 (World Health Organization, 2021). Among the countries in south-east Asia, Indonesia has the most active COVID-19 cases (Dong et al., 2020), and the nation’s case fatality rate was higher than the global average (2.7% vs 2.2%) at the end of February 2021 (Kementerian Kesehatan Republik Indonesia, 2021).